Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Prescription d’opioïdes : un rappel des bonnes pratiques

Guide | 2023
les guides de pratique clinique, à propos des prescripteurs, à propos des pharmaciens, la surdose, la mortalité, la politique / le cadre de réglementation

Point-of-care Emergency Clinical Summary: Treatment of Benzodiazepine Toxicity and the Use of Flumazenil

Guidelines | 2022
Overdose, Clinical guidance

Large Variation in Provincial Guidelines for Urine Drug Screening During Opioid Agonist Treatment in Canada

We conducted a policy scan of UDS guidelines, examining the published clinical practice guidelines for each Canadian province and extracting all relevant data in March 2017.

Guidelines | 2018
Clinical guidance, Substitution/OAT, About prescribers

Guide d’utilisation de la buprénorphine injectable à libération prolongée (SublocadeMC) dans le cadre d’un traitement par agonistes opioïdes (TAO)

Guide | 2023
les guides de pratique clinique, le traitement de substitution/TAO

Injection mensuelle de buprénorphine à libération prolongée

Guide | 2023
les guides de pratique clinique, à propos des prescripteurs, le traitement de substitution/TAO

Prescribed Safer Supply Protocols - Fentanyl Patch

Guidelines | 2023
Clinical guidance, Harm reduction, Safer supply, About prescribers

Urine Drug Testing in Clinical Practice

Guidelines | 2015
Clinical guidance, About prescribers

Extended-release monthly buprenorphine injection

Guidelines | 2023
Clinical guidance, About prescribers, Substitution/OAT

Collecting data on safer supply prescribing starts with correctly completing the duplicate prescription form

Guidelines | 2022
Clinical guidance, Safer supply, Policy/Regulatory, About prescribers

CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022

Guidelines | 2022
Clinical guidance, About prescribers

Emergency Department Toolkit for Opioid Use Disorder

Guidelines | 2022
About prescribers, Substitution/OAT, Hospitals, Clinical guidance

Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection

Guide | 2015
les guides de pratique clinique, les services enveloppants

Clinical Management of Opioid Withdrawal

Guidelines | 2022
Withdrawal, Clinical guidance, Harm reduction, About prescribers

Methadone treatment for patients who use fentanyl: Recommendations

Guidelines | 2021
Clinical guidance, Policy/Regulatory, About prescribers, Illegal drugs, Substitution/OAT, Carries/take-home doses

Methadone treatment for patients who use fentanyl: Plain language summary

Guidelines | 2021
Clinical guidance, Policy/Regulatory, About prescribers, Substitution/OAT, Carries/take-home doses, Illegal drugs

Opioid Use Disorder Practice Update

Guidelines | 2022
Clinical guidance, Policy/Regulatory, About prescribers, Harm reduction, Safer supply, Carries/take-home doses, Substitution/OAT

Methadone Take-Home Flexibilities Extension Guidance

Guidelines | 2022
Clinical guidance, Carries/take-home doses, Policy/Regulatory

Hydromorphone Tablet (TiOAT) Clinical Care Standard

Guidelines | 2019
Clinical guidance, About prescribers, Injecting drugs, Safer supply

Diagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art Review

Guidelines | 2022
Clinical guidance, About prescribers, Injecting drugs

Guidance Document on the Management of Substance Use in Acute Care

Guidelines | 2020
Clinical guidance, Advocacy, Barriers and enablers, Hospitals, About prescribers

Affiner votre recherche

Mots clés
Format
Région